ReviewFrontiers in aging neuroscience2022

Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer's disease.

Jianwen Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.